GL1X · GenesisL1 explorer

Research workbench

SARS-cov-spike rbd bound to two neutralising nanobodies.

Analyse SARS-cov-spike rbd bound to two neutralising nanobodies. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7B17
Type
protein
Length
445 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; SARS-cov-2 neutralizing biparatopic nanobody VE,NANOBODY E from lama…
UniProt
P0DTC2
Ligands
NAG
Pockets
3 · best druggability 0.55

Structure

electron microscopy · 2 distinct chains · 10% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike protein S1protein19518% helix, 30% strandP0DTC2
BSARS-cov-2 neutralizing biparatopic nanobody VE,NANOBODY E from lama GLAMA,SARS-cov-2 neutralizing biparatopic nanobody ve, nanobody E from lama glamaprotein2504% helix, 49% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12090.550.7925empty
2850.320.7319empty
3500.260.7416empty

Interfaces

1 interface between chains.

  • A–B · 1978 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7B17 · SARS-CoV-spike RBD bound to two neutralising nanobodies. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.